Lotrel - 55154-9668-8 - (amlodipine besylate and benazepril hydrochloride)

Alphabetical Index


Drug Information of Lotrel

Product NDC: 55154-9668
Proprietary Name: Lotrel
Non Proprietary Name: amlodipine besylate and benazepril hydrochloride
Active Ingredient(s): 10; 40    mg/1; mg/1 & nbsp;   amlodipine besylate and benazepril hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Lotrel

Product NDC: 55154-9668
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020364
Marketing Category: NDA
Start Marketing Date: 19950303

Package Information of Lotrel

Package NDC: 55154-9668-8
Package Description: 2400 CAPSULE in 1 BOTTLE, PLASTIC (55154-9668-8)

NDC Information of Lotrel

NDC Code 55154-9668-8
Proprietary Name Lotrel
Package Description 2400 CAPSULE in 1 BOTTLE, PLASTIC (55154-9668-8)
Product NDC 55154-9668
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name amlodipine besylate and benazepril hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19950303
Marketing Category Name NDA
Labeler Name Cardinal Health
Substance Name AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Strength Number 10; 40
Strength Unit mg/1; mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]

Complete Information of Lotrel


General Information